MSFT 417.14 0.9731% AAPL 229.0 -0.3438% NVDA 119.37 1.5137% GOOGL 163.38 0.989% GOOG 165.11 1.0465% AMZN 178.5 3.7067% META 521.31 0.5963% AVGO 162.82 3.7533% TSLA 214.11 3.7958% TSM 171.7 1.5075% LLY 960.02 2.1081% V 276.37 0.7473% JPM 224.8 1.1656% UNH 590.2 -0.2316% NVO 139.16 1.1926% WMT 77.23 1.0599% LVMUY 149.005 -0.3844% XOM 117.94 -0.1608% LVMHF 745.0 -0.4011% MA 483.34 0.5283%
Last update at 2024-09-05T06:10:00Z
Cochlear Limited's (ASX:COH) Intrinsic Value Is Potentially 19% Below Its Share Price
Sun 01 Sep 24, 12:01 AMCochlear Full Year 2024 Earnings: EPS Misses Expectations
Sat 17 Aug 24, 11:16 PMHere's Why We Think Cochlear (ASX:COH) Might Deserve Your Attention Today
Thu 15 Aug 24, 02:41 AMWhat Makes CochLear Ltd. Unsponsored ADR (CHEOY) a New Buy Stock
Wed 17 Jul 24, 04:00 PMCochlear Limited's (ASX:COH) Stock Been Rising: Are Strong Financials Guiding The Market?
Tue 14 May 24, 05:30 AMCochlear (ASX:COH) May Have Issues Allocating Its Capital
Sat 27 Apr 24, 10:49 PMInvesting in Cochlear (ASX:COH) five years ago would have delivered you a 104% gain
Mon 25 Mar 24, 02:35 AMShould You Be Adding Cochlear (ASX:COH) To Your Watchlist Today?
Fri 08 Mar 24, 02:19 AMAre Medical Stocks Lagging Masimo (MASI) This Year?
Fri 23 Feb 24, 02:40 PMCochlear announces 2024 winners of annual scholarships
Thu 22 Feb 24, 03:15 PMBreakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Income before tax | 396.60M | 393.80M | 365.70M | -271.10000M | 365.60M |
Minority interest | - | - | - | - | - |
Net income | 300.60M | 289.10M | 326.50M | -238.30000M | 276.70M |
Selling general administrative | 203.90M | 159.00M | 112.20M | 93.80M | 94.80M |
Selling and marketing expenses | 606.50M | 498.70M | 444.10M | 470.00M | 450.90M |
Gross profit | 1448.10M | 1237.30M | 1087.40M | 976.20M | 1075.60M |
Reconciled depreciation | 80.90M | 73.00M | 79.50M | 28.85M | 38.50M |
Ebit | 406.00M | 402.40M | 377.70M | -243.90000M | 370.80M |
Ebitda | 486.90M | 475.40M | 457.20M | -166.40000M | 409.30M |
Depreciation and amortization | 80.90M | 73.00M | 79.50M | 77.50M | 38.50M |
Non operating income net other | - | - | - | - | - |
Operating income | 406.30M | 380.90M | 340.50M | 219.70M | 370.80M |
Other operating expenses | 570.60M | 426.30M | 307.00M | 871.00M | 1119.70M |
Interest expense | 9.40M | 8.60M | 12.00M | 10.50M | 5.20M |
Tax provision | 96.00M | 104.70M | 39.20M | -32.80000M | 88.90M |
Interest income | 7.10M | 2.40M | 3.60M | 8.90M | 4.50M |
Net interest income | 7.10M | -6.20000M | -8.40000M | -10.50000M | -4.50000M |
Extraordinary items | - | - | - | - | 0.00000M |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 96.00M | 104.70M | 39.20M | -32.80000M | 88.90M |
Total revenue | 1936.10M | 1648.30M | 1497.60M | 1320.60M | 1426.70M |
Total operating expenses | 1136.20M | 941.40M | 855.40M | 839.50M | 768.60M |
Cost of revenue | 488.00M | 411.00M | 410.20M | 344.40M | 351.10M |
Total other income expense net | -3.30000M | 31.10M | 62.60M | -476.40000M | -5.20000M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 300.60M | 289.10M | 326.50M | -238.30000M | 276.70M |
Net income applicable to common shares | 300.60M | 289.10M | 326.50M | -238.30000M | 276.70M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Total assets | 2568.70M | 2465.10M | 2438.20M | 2575.70M | 1379.20M |
Intangible assets | 188.00M | 135.40M | 135.50M | 139.40M | 155.60M |
Earning assets | - | - | - | - | - |
Other current assets | 57.00M | 79.00M | 108.00M | 88.20M | 41.30M |
Total liab | 819.90M | 779.40M | 736.50M | 1174.20M | 653.30M |
Total stockholder equity | 1748.80M | 1685.70M | 1701.70M | 1401.50M | 725.90M |
Deferred long term liab | - | 33.00M | 53.30M | 58.10M | 50.40M |
Other current liab | 206.80M | 161.80M | 124.90M | 192.10M | 152.50M |
Common stock | 1250.30M | 1276.60M | 1276.60M | 1272.40M | 182.30M |
Capital stock | 1250.30M | 1276.60M | 1276.60M | 1272.40M | 182.30M |
Retained earnings | 555.40M | 455.30M | 367.20M | 116.40M | 558.90M |
Other liab | 79.30M | 76.60M | 101.60M | 71.30M | 115.50M |
Good will | 256.10M | 257.10M | 267.30M | 270.90M | 268.80M |
Other assets | 126.90M | 220.30M | 203.40M | 212.30M | 155.90M |
Cash | 555.50M | 629.30M | 609.60M | 565.00M | 78.60M |
Cash and equivalents | 555.50M | 629.30M | 609.60M | 565.00M | 78.60M |
Total current liabilities | 578.00M | 527.60M | 402.50M | 817.50M | 359.50M |
Current deferred revenue | 61.60M | 54.70M | 42.80M | 47.00M | 42.90M |
Net debt | -353.70000M | -375.40000M | -345.30000M | 139.50M | 103.00M |
Short term debt | 39.20M | 78.70M | 31.90M | 419.10M | 3.30M |
Short long term debt | - | 42.60M | - | 393.10M | 3.30M |
Short long term debt total | 201.80M | 253.90M | 264.30M | 704.50M | 181.60M |
Other stockholder equity | -1805.70000M | -1731.90000M | -1631.70000M | -1388.80000M | -15.30000M |
Property plant equipment | 447.20M | 439.20M | 428.50M | 438.80M | 166.50M |
Total current assets | 1361.50M | 1327.00M | 1230.00M | 1477.50M | 635.00M |
Long term investments | 97.30M | 119.10M | 199.50M | 94.90M | 47.80M |
Net tangible assets | 1304.70M | 1326.20M | 1352.20M | 1049.30M | 351.90M |
Short term investments | 90.80M | 68.80M | 27.30M | 365.00M | 365.00M |
Net receivables | 437.50M | 348.50M | 296.30M | 235.50M | 319.70M |
Long term debt | - | 0.00000M | 45.00M | 79.90M | 178.30M |
Inventory | 311.50M | 270.20M | 216.10M | 223.80M | 195.40M |
Accounts payable | 270.40M | 232.40M | 202.90M | 159.30M | 160.80M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -56.90000M | -46.20000M | 57.90M | 12.70M | -15.30000M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | 1272.40M | 182.30M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 93.30M | 71.20M | 30.60M | 7.10M | 5.40M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 1207.20M | 1138.10M | 1208.20M | 1098.20M | 744.20M |
Capital lease obligations | 201.80M | 211.30M | 219.30M | 231.50M | - |
Long term debt total | 162.60M | 175.20M | 232.40M | 285.40M | 178.30M |
Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Investments | -125.70000M | -61.70000M | 346.60M | -379.20000M | -23.20000M |
Change to liabilities | 31.80M | 89.80M | 65.00M | -65.00000M | 29.10M |
Total cashflows from investing activities | -125.70000M | -138.90000M | 274.00M | -509.70000M | -137.80000M |
Net borrowings | -72.70000M | -25.60000M | -421.90000M | 266.30M | 33.50M |
Total cash from financing activities | -310.40000M | -220.70000M | -495.10000M | 1154.50M | -140.90000M |
Change to operating activities | 31.90M | 8.90M | -108.90000M | 122.40M | -13.60000M |
Net income | 300.60M | 289.10M | 323.80M | -238.30000M | 276.70M |
Change in cash | -73.80000M | 19.70M | 44.60M | 486.40M | 17.10M |
Begin period cash flow | 629.30M | 609.60M | 565.00M | 78.60M | 61.50M |
End period cash flow | 555.50M | 629.30M | 609.60M | 565.00M | 78.60M |
Total cash from operating activities | 362.40M | 376.50M | 265.40M | -157.80000M | 296.00M |
Issuance of capital stock | - | 1.10M | 2.40M | 862.50M | 7.40M |
Depreciation | 71.90M | 64.50M | 68.80M | 66.70M | 38.50M |
Other cashflows from investing activities | -29.80000M | -61.70000M | 346.60M | -379.20000M | -23.20000M |
Dividends paid | 197.40M | 194.00M | 75.60M | 193.70M | 181.80M |
Change to inventory | -41.30000M | -54.10000M | 7.70M | -28.40000M | -28.00000M |
Change to account receivables | -89.00000M | -52.20000M | -60.80000M | 82.50M | -4.20000M |
Sale purchase of stock | -29.60000M | -29.60000M | 1.70M | 219.40M | 219.40M |
Other cashflows from financing activities | -42.10000M | -25.60000M | -20.50000M | 396.30M | 219.70M |
Change to netincome | 23.30M | -7.60000M | -43.60000M | -23.70000M | -12.60000M |
Capital expenditures | 95.90M | 77.20M | 72.60M | 130.50M | 114.60M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | -130.30000M | -106.30000M | -53.10000M | 54.10M | 8.10M |
Stock based compensation | 15.90M | 10.80M | 8.10M | 7.00M | - |
Other non cash items | -10.10000M | 22.90M | -127.20000M | 13.80M | -315.20000M |
Free cash flow | 266.50M | 299.30M | 192.80M | -288.30000M | 181.40M |
Sector: Healthcare Industry: Medical Devices
Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
COH Cochlear Ltd |
-2.62 0.89% | 291.89 | 62.84 | 46.30 | 9.75 | 11.76 | 9.62 | 36.63 |
PNV Polynovo Ltd |
-0.04 1.71% | 2.30 | - | 140.85 | 17.37 | 21.49 | 17.51 | 647.42 |
AVH Avita Therapeutics Inc |
0.07 2.79% | 2.58 | - | - | 8.59 | 5.71 | 6.72 | -10.0538 |
EBR Ebr Systems Inc CDR |
-0.015 1.43% | 1.03 | - | - | - | 5.68 | -7.482 | |
AVR Anteris Technologies Ltd |
-0.9 7.63% | 10.90 | - | - | 104.23 | 14.98 | 95.15 | -5.9152 |
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
1 University Avenue, Sydney, NSW, Australia, 2109
Name | Title | Year Born |
---|---|---|
Mr. Diggory William Howitt BE (Hons), MBA | CEO, MD, Pres & Exec. Director | 1967 |
Mr. Stuart Sayers | Chief Financial Officer | NA |
Mr. Jan Janssen MSc Elec Eng | Chief Technology Officer | 1965 |
Mr. Anthony Bishop | Pres of Asia Pacific & Latin America | NA |
Ms. Lisa Aubert | Pres of North America | NA |
Mr. Richard Brook MBA | Pres of EMEA | NA |
Mr. David Hackshall | Chief Information Officer | NA |
Ms. Kristina Devon | VP of Investor Relations | NA |
Ms. Jennifer Stevenson | VP of Corp. Communications & Brand | NA |
Mr. Dean Phizacklea | Sr. VP of Global Strategic Marketing | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.